We offer a comprehensive autoimmunity product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications.
Anti-MAG Autoantibodies ELISA
US: Research Use Only. Not for use in diagnostic procedures.
Canada: Health Canada License: 89118
This assay is intended for the quantitative determination of human IgM-auto-antibodies directed against Myelin Associated Glycoprotein (MAG) in serum.
Based on human myelin, the Anti-MAG Autoantibodies ELISA from BÜHLMANN is the most sensitive and specific assay on the market.
Our anti-MAG Autoantibody ELISA is an ideal research tool with superior sensitivity to Westernblot (captures ~ 30% more positive samples than Westernblot)
Advantages
Accuracy: Pre-coated microtiter plates.
Specificity: The use of highly purified human MAG as an antigen, microtiter plates with extremely low unspecific binding properties, no blocking proteins, and we offer pre-measured standards and two controls.
Standardization: Standard curve with titer units.
Quantitation: Allowing the study of treatment efficacy(e.g. Rituximab).
VIEW ALL NEUROIMMUNOLOGY ASSAYS
Autoimmunity Assays:
BUHLMANN has a full list of Autoimmunity assays. Learn more about our Quantum Blue® sCAL , CIC-C1q ELISA, and Anti-C1q Autoantibodies ELISA
VIEW ALL AUTOIMMUNITY ASSAYS
Other Assays of Interest:
Allergy:
Flow CAST®
US: Research Use Only. Not for use in diagnostic procedures.
Canada: Health Canada Licence: 101781
BÜHLMANN’s Flow CAST®Assay for Allergy provides an efficient method for cellular allergy stimulation testing using a broad range of quality controlled allergens and mixes which are standardized and validated for use in this assay and the CAST® ELISA.
Calprotectin:
The BÜHLMANN fCAL® ELISA is an in vitro diagnostic assay intended for the quantitative measurement of fecal calprotectin in human stool. The BÜHLMANN fCAL® ELISA aids in the diagnosis of inflammatory bowel disease (IBD), specifically Crohn’s disease (CD) and ulcerative colitis (UC) and aids in the differentiation of IBD from irritable bowel syndrome (IBS) in conjunction with other laboratory and clinical findings.
This FDA 510k cleared, non-invasive, sensitive and specific assay is accurate, precise, efficient and offers reliable information to aid clinicians in selecting patients for further diagnostic procedures.
- Robust: accurate, precise & efficient assay to instill confidence
- Validated: in use worldwide providing over 1 million reliable patient results a year
- Published: highly referenced, >75 peer reviewed scientific articles
The BÜHLMANN fCAL® turbo is an in vitro diagnostic assay intended for the quantitative measurement of fecal calprotectin, a neutrophilic protein that is a marker of intestinal mucosal inflammation, in human stool. The BÜHLMANN fCAL® turbo aids in the diagnosis of inflammatory bowel disease (IBD), specifically Crohn’s disease (CD) and ulcerative colitis (UC) and aids in the differentiation of IBD from irritable bowel syndrome (IBS) in conjunction with other laboratory and clinical findings.
This FDA 510k cleared, non-invasive, sensitive and specific assay is unique in speed, quality, and flexibility. This offers accurate results and reliable information to aid clinicians in selecting patients for further diagnostic procedures.
- Speed: fastest calprotectin test in the market, time-to-first-result within 10 minutes
- Quality: standardized against BÜHLMANN fCAL® ELISA, uses highly precise and reproducible PETIA technology
- Flexibility: can be applied on most open chemistry platforms streamlining your workflow using random access automation
Jennifer Stuart
Technical Sales Specialist
Jennifer joined BDC as a Technical Sales Specialist in 2016, having spent 17 years performing Clinical Microbiology and Molecular Diagnostics in various hospital laboratory settings including MA General Hospital and Southern New Hampshire Medical Center. She is ASCP certified and received her BS in Medical Technology at the University of New Hampshire.
